Banco Santander’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-24,274
| Closed | -$1.6M | – | 469 |
|
2024
Q3 | $1.6M | Sell |
24,274
-502
| -2% | -$33.1K | 0.02% | 244 |
|
2024
Q2 | $2.29M | Sell |
24,776
-739
| -3% | -$68.3K | 0.03% | 224 |
|
2024
Q1 | $2.44M | Sell |
25,515
-71,729
| -74% | -$6.85M | 0.03% | 223 |
|
2023
Q4 | $7.41M | Buy |
97,244
+1,911
| +2% | +$146K | 0.09% | 139 |
|
2023
Q3 | $6.6M | Buy |
95,333
+9,481
| +11% | +$657K | 0.09% | 139 |
|
2023
Q2 | $8.1M | Buy |
85,852
+112
| +0.1% | +$10.6K | 0.11% | 119 |
|
2023
Q1 | $7.09M | Buy |
85,740
+11,338
| +15% | +$938K | 0.1% | 103 |
|
2022
Q4 | $5.55M | Buy |
74,402
+4,588
| +7% | +$342K | 0.08% | 121 |
|
2022
Q3 | $5.77M | Hold |
69,814
| – | – | 0.08% | 127 |
|
2022
Q2 | $6.64M | Buy |
+69,814
| New | +$6.64M | 0.09% | 121 |
|
2021
Q4 | – | Sell |
-2,319
| Closed | -$263K | – | 427 |
|
2021
Q3 | $263K | Buy |
+2,319
| New | +$263K | ﹤0.01% | 386 |
|
2021
Q2 | – | Sell |
-3,251
| Closed | -$272K | – | 405 |
|
2021
Q1 | $272K | Sell |
3,251
-2,502
| -43% | -$209K | ﹤0.01% | 365 |
|
2020
Q4 | $525K | Sell |
5,753
-5,735
| -50% | -$523K | ﹤0.01% | 308 |
|
2020
Q3 | $917K | Sell |
11,488
-2,819
| -20% | -$225K | 0.01% | 236 |
|
2020
Q2 | $989K | Buy |
14,307
+1,791
| +14% | +$124K | 0.01% | 221 |
|
2020
Q1 | $787K | Buy |
12,516
+1,824
| +17% | +$115K | 0.01% | 265 |
|
2019
Q4 | $831K | Buy |
+10,692
| New | +$831K | 0.01% | 280 |
|
2018
Q4 | – | Sell |
-3,945
| Closed | -$229K | – | 359 |
|
2018
Q3 | $229K | Sell |
3,945
-403,806
| -99% | -$23.4M | ﹤0.01% | 343 |
|
2018
Q2 | $19.8M | Buy |
407,751
+402,756
| +8,063% | +$19.5M | 0.23% | 63 |
|
2018
Q1 | $232K | Sell |
4,995
-160,278
| -97% | -$7.44M | ﹤0.01% | 373 |
|
2017
Q4 | $6.21M | Buy |
165,273
+117,273
| +244% | +$4.41M | 0.09% | 88 |
|
2017
Q3 | $1.75M | Hold |
48,000
| – | – | 0.03% | 127 |
|
2017
Q2 | $1.89M | Buy |
+48,000
| New | +$1.89M | 0.04% | 97 |
|